Account
Inquiry
Tirzepatide 15mg is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This synthetic peptide demonstrates superior efficacy in glucose control and weight management compared to single-agonist compounds.
The tirzepatide 15mg formulation exhibits greater binding affinity for GIP receptors than GLP-1 receptors, producing enhanced hypoglycemic effects. Research indicates this dual agonist mechanism mimics natural GIP activity while delivering the metabolic benefits of GLP-1 activation.
Our pharmaceutical-grade tirzepatide 15mg is supplied as a white lyophilized powder with purity exceeding 99%. The compound is packaged in sterile vials under inert atmosphere to ensure stability and longevity.
Available in standard 15mg vials, we also offer custom formulation services for specific research requirements. Bulk quantities can be supplied with customized packaging solutions including private labeling.
Note: This product is intended for research purposes only. Not for human consumption or diagnostic use. Proper laboratory handling procedures should be followed at all times.
